Annotation Detail

Information
Associated Genes
SETD2
Associated Variants
SETD2 MUTATION
SETD2 MUTATION
Associated Disease
Conventional (Clear Cell) Renal Cell Carcinoma
Source Database
DisGeNET
Description
Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutation.
Pubmed
25528216
Section of the abstract supporting the evidence
TITLE
Number of the section of the abstract supporting the evidence
0
Number of the sentence supporting the evidence
0
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00352874433704394
Drugs